“Developmental clock compromises human twin model created by embryo splitting.” Noli L, Dajani Y, Capalbo A, Bvumbe J, Rienzi L, Ubaldi FM, Ogilvie C, Khalaf Y, Ilic D. Hum Reprod. 2015 Oct 21. Pubmed
“From transcriptomic to protein level changes in TDP-43 and FUS loss-of-function cell models.” Colombrita C, Onesto E, Buratti E, de la Grange P, Gumina V, Baralle FE, Silani V, Ratti A. Biochim Biophys Acta. 2015 Oct 26. Pubmed
“Molecular analyses of juvenile granulosa cell tumors bearing AKT1 mutations provide insights into tumor biology and therapeutic leads.” Auguste A, Bessière L, Todeschini AL, Caburet S, Sarnacki S, Prat J, D’Angelo E, de la Grange P, Ariste O, Lemoine F, Legois B, Sultan C, Zider A, Galmiche L, Kalfa N, Read more…
“TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways” De Conti L, Akinyi MV, Mendoza-Maldonado R, Romano M, Baralle M, Buratti E. NAR. 2015 Aug. Pubmed
“SNORD116 and SNORD115 change expression of multiple genes and modify each other’s activity.” Falaleeva M, Surface J, Shen M, de la Grange P, Stamm S. Gene. 2015 Jul. Pubmed
“DUSP4-mediated accelerated T-cell senescence in idiopathic CD4 lymphopenia.” Bignon A, Régent A, Klipfel L, Desnoyer A, de la Grange P, Martinez V, Lortholary O, Dalloul A, Mouthon L, Balabanian K. Blood. 2015 March 02 Pubmed
“Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells – high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation.” Bruserud Ø, Reikvam H, Fredly H, Skavland J, Hagen KM, van Hoang TT, Brenner AK, Kadi A, Astori A, Gjertsen Read more…
“Amplicon rearrangements during the extrachromosomal and intrachromosomal amplification process in a glioma” Vogt N, Gibaud A, Lemoine F, de la Grange P, Debatisse M, Malfoy B. Pubmed
“Regulation of FAS Exon Definition and Apoptosis by the Ewing Sarcoma Protein” Paronetto MP, Bernardis I, Volpe E, Bechara E, Sebestyén E, Eyras E, Valcárcel J. Pubmed
“Acquired resistance to endocrine treatments is associated to tumor-specific molecular changes in patient-derived luminal breast cancer xenografts.” Cottu PH, Bieche I, Assayag F, El Botty R, Chateau-Joubert S, Thuleau A, Bagarre T, Albaud B, Rapinat A, Gentien D, de la Grange P, Sibut V, Vacher S, Hatem R, Severly JL, Read more…